Miguel Romero Cuevas

Title: Miguel Romero Cuevas: Innovator in GLP-1 Modulation

Introduction

Miguel Romero Cuevas is a notable inventor based in Málaga, Spain. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that modulate the GLP-1 peptide receptor. His work is crucial in addressing various metabolic disorders.

Latest Patents

Miguel holds a patent for "1,2,4-oxadiazole derivatives as drugs modulating the GLP-1 peptide receptor." This invention relates to the use of a compound of formula (I) or a pharmaceutically acceptable solvate or salt thereof in the preparation of a medicinal product. The patent aims to prevent and treat diseases in which the GLP-1 receptor participates or mediates, such as eating disorders, obesity, anorexia, lipid dysfunction, diabetes, hyperinsulinism, cardiovascular diseases, and metabolic syndrome. He has 1 patent to his name.

Career Highlights

Miguel Romero Cuevas is associated with Vivia Biotech S.L., where he applies his expertise in drug development. His innovative approach has positioned him as a key player in the pharmaceutical industry, focusing on therapeutic solutions for complex health issues.

Collaborations

Throughout his career, Miguel has collaborated with esteemed colleagues, including Fernando Rodríguez De Fonseca and Laura Orio Ortíz. These partnerships have enhanced his research and contributed to the advancement of his projects.

Conclusion

Miguel Romero Cuevas is a pioneering inventor whose work in GLP-1 modulation holds promise for treating various metabolic disorders. His contributions to medicinal chemistry are invaluable, and his ongoing research continues to impact the field positively.